MktsMarkets

Aquestive Therapeutics, Inc.
NASDAQ: AQSTKey statistics
AQST News
Stories mentioning AQST from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 14,446 | 13,015 | 12,807 | 10,003 | 8,720 | 11,867 | 13,542 | 20,099 |
| Cost of Goods Sold | 3,469 | 5,836 | 4,506 | 4,561 | 3,652 | 4,520 | 4,437 | 4,526 |
| Gross Profit | 10,977 | 7,179 | 8,301 | 5,442 | 5,068 | 7,347 | 9,105 | 15,573 |
| Operating Expenses | ||||||||
| Research & Development | 4,204 | 3,196 | 4,530 | 4,105 | 5,361 | 4,917 | 5,269 | 4,162 |
| Sales General & Admin | 10,977 | 32,822 | 15,250 | 12,705 | 19,072 | 16,009 | 12,126 | 11,356 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (4,204) | (28,839) | (11,479) | (11,368) | (19,365) | (13,579) | (8,290) | 55.00 |
| Interest Income | ||||||||
| Interest Expense | 2,779 | |||||||
| Other Expense | ||||||||
| Pretax Income | (8,057) | (31,860) | (15,446) | (13,548) | (22,930) | (17,069) | (11,509) | (2,745) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (14.00) | 0.00 | 0.00 |
| Net Income (Loss) | (8,057) | (31,860) | (15,446) | (13,548) | (22,930) | (17,055) | (11,509) | (2,745) |
| Earnings Per Share (Basic) | (0.07) | (0.30) | (0.14) | (0.14) | (0.24) | (0.20) | (0.13) | (0.03) |
| Earnings Per Share (Diluted) | (0.07) | (0.30) | (0.14) | (0.14) | (0.24) | (0.20) | (0.13) | (0.03) |
| Weighted Average Shares Outstanding (Basic) | 122,610 | 106,927 | 110,584 | 99,327 | 95,497 | 86,726 | 91,082 | 90,912 |
| Weighted Average Shares Outstanding (Diluted) | 122,610 | 106,927 | 110,584 | 99,327 | 95,497 | 86,726 | 91,082 | 90,912 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AQST
Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a stock listed on the Nasdaq Stock Market under the ticker symbol AQST. It last traded at $3.57 (Nov 12, 2026, 4:00 PM ET), down 0.3% on the day. That gives Aquestive Therapeutics a market capitalisation of $445.6M.
Over the past 52 weeks AQST has traded between $2.93 and $6.74.
Revenue for the quarter ended Mar 31, 2026 was $14.4M; a net loss of $8.1M. Revenue was up 65.7% from $8.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $14.4M | -$8.1M | -55.8% |
| Dec 31, 2025 | $13.0M | -$31.9M | -244.8% |
| Sep 30, 2025 | $12.8M | -$15.4M | -120.6% |
| Jun 30, 2025 | $10.0M | -$13.5M | -135.4% |
From Aquestive Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…